Introducing Ophteis^® FR Pro with sorbitol – for Free Radical Scavenging (FRS)

On March 7th 2016, Rayner launches a new OVD –

Professor Steve Arshinoff discusses the importance of viscoelastic in cataract surgery at Rayner's Ophteis Acquisitio...

Rayner will be hosting a very special ESCRS event to mark the recent acquisition of the Ophteis OVD portfolio.

Professor Steve Arshinoff and Rayner CEO Tim Clover will make a short speech before inviting guests to join the celebration w...

DECEMBER 22, 2021 – Worthing, United Kingdom. Rayner, a leading UK-based ophthalmic company focused on optimising visual outcomes for surgeons and their patients, is delighted to announce the appointment of Drs Eric Donnenfeld, Kerry Solomon, Vance Thompson, and Mr Jim Mazzo as strategic advisors to the business, with a specific focus on supporting the expansion

DECEMBER 02, 2021 – Worthing, United Kingdom. Rayner Surgical Group (‘Rayner’) and Omeros Corporation (‘Omeros’) are delighted to announce the transfer of Omeros’ ophthalmology assets, including OmidriaTM, to Rayner. This will enable the creation of a significant commercial, regulatory and marketing infrastructure in the US, with a broad range of products, including intraocular lenses (IOLs), for cataract surgeons.

NOVEMBER 24, 2021 – Worthing, United Kingdom. Rayner, a leading ophthalmology company focused on optimising visual outcomes for patients and surgeons, today announced the appointment of Dr Rob Nadler to the role of VP Corporate Development. Dr Nadler will play a critical role on the executive team, overseeing the company’s M&A strategy and brings invaluable clinical,

AUGUST 04, 2021 – Worthing, United Kingdom. Rayner, the pioneering manufacturer of intraocular lenses for cataract and refractive surgery, announced today that it has achieved the milestone figure of 1,000 intraocular lenses recorded on RayPRO, its digital patient reported outcomes platform. Launched at ASCRS in 2019 for ophthalmic surgeons who perform cataract procedures, RayPRO is

JUNE 18, 2021 – Worthing, United Kingdom. Rayner, the pioneering manufacturer of intraocular lenses for cataract and refractive surgery, announced today that it has acquired Surgicon Healthcare Pvt Limited in Mumbai, India. The acquisition closed on Friday 18th June 2021. Acquisition Details Rayner has acquired its exclusive Indian distributor, Surgicon, for an undisclosed price. The

New York, USA, May 17, 2021 – RayOne Spheric, a fully-preloaded monofocal IOL, has received FDA approval. This achievement marks Rayner’s third FDA approval in under three years within its expanding RayOne preloaded IOL portfolio. RayOne Spheric joins RayOne Aspheric (FDA approved December 2018) and RayOne EMV, a new non-diffractive IOL solution which achieved FDA

Takeaways: Rayner’s fully preloaded RayOne Aspheric IOL has received NMPA approval for sale in China. RayOne Aspheric will be showcased at the 21st CSCRS from 3-5 June 2021 in Dalian. RayOne Aspheric offers a premium alternative to Rayner’s C-flex/Superflex Aspheric monofocal IOLs. Rayner’s award-winning RayOne IOL platform has been used in over 1.6 million procedures since 2016. Rayner will next

Worthing, UK, 3 May 2021 – With the global rollout of the RayOne EMV™ intraocular lens to markets around the world, Rayner announces today an exciting new campaign intended to extoll the benefits of monovision (including “Mini”, “Micro”, or “Blended”). The Plus1 EMV: A global discussion on Enhanced Monovision™ campaign will shine a light on

Rayner is proud to have supplied Dr Woodruff with Rayner C-flex Aspheric Monofocal IOLs and OphteisBio 3% OVD for his recent visit to Ethiopia as Visiting Professor & Mentor in Paediatric Ophthalmology, Gondar University Hospital 25th March...

For those of you who have visited the Rayner website over the last few days, you will have noticed we’re now offering a very different online experience; one that we believe is clearer and more user-friendly.

It’s al...